Investors continued to see multiple shades of light red Thursday as biotechs continued to struggle in the wake of the ...
Lord Burnett of Maldon part of panel supporting former Conservative lord chancellor as review issues call for evidence.
Healthequity (HQY) In a report released yesterday, David Larsen from BTIG maintained a Buy rating on Healthequity, with a price target of $130.00. The company’s shares closed last Wednesday at $94.80, ...
In a report released yesterday, David Larsen from BTIG maintained a Hold rating on P3 Health Partners (PIII – Research Report). The ...